These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15823492)

  • 1. The inflammation: lipoprotein cycle.
    Barter P
    Atheroscler Suppl; 2005 May; 6(2):15-20. PubMed ID: 15823492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the anti-inflammatory effects of high-density lipoprotein.
    Ansell BJ
    Am J Cardiol; 2007 Dec; 100(11 A):n3-9. PubMed ID: 18047850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scavenger receptors in atherosclerosis: beyond lipid uptake.
    Moore KJ; Freeman MW
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1702-11. PubMed ID: 16728653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I; Pan XM; Rapp JH; Feingold KR
    Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.
    Zambon A; Gervois P; Pauletto P; Fruchart JC; Staels B
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):977-86. PubMed ID: 16424352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.
    Tabas I; Williams KJ; Borén J
    Circulation; 2007 Oct; 116(16):1832-44. PubMed ID: 17938300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiinflammatory properties of HDL.
    Barter PJ; Nicholls S; Rye KA; Anantharamaiah GM; Navab M; Fogelman AM
    Circ Res; 2004 Oct; 95(8):764-72. PubMed ID: 15486323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
    Kontush A; Chapman MJ
    Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis.
    Spiteller G
    Mol Nutr Food Res; 2005 Nov; 49(11):999-1013. PubMed ID: 16270286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of second-hand smoke on biological processes important in atherogenesis.
    Yuan H; Wong LS; Bhattacharya M; Ma C; Zafarani M; Yao M; Schneider M; Pitas RE; Martins-Green M
    BMC Cardiovasc Disord; 2007 Jan; 7():1. PubMed ID: 17210084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertrygliceridemia as a factor of atherogenesis: significance and mechanisms of action].
    Ambroskina VV; Kriachok TA; Larionov OP; Bratus' VV; Talaieva TV
    Fiziol Zh (1994); 2008; 54(5):61-70. PubMed ID: 19058514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic studies of atherogenic lipoproteins in hemodialysis patients: do they tell us more about their pathology?
    Kronenberg F; Ikewaki K; Schaefer JR; König P; Dieplinger H
    Semin Dial; 2007; 20(6):554-60. PubMed ID: 17991204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice.
    She ZG; Zheng W; Wei YS; Chen HZ; Wang AB; Li HL; Liu G; Zhang R; Liu JJ; Stallcup WB; Zhou Z; Liu DP; Liang CC
    Circ Res; 2009 May; 104(10):1160-8. PubMed ID: 19359600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus.
    Hogue JC; Lamarche B; Tremblay AJ; Bergeron J; Gagné C; Couture P
    Metabolism; 2008 Mar; 57(3):380-6. PubMed ID: 18249211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized low-density lipoprotein: a double-edged sword on atherosclerosis.
    Yu BL; Zhao SP; Huang XS
    Med Hypotheses; 2007; 69(3):553-6. PubMed ID: 17368957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular inflammation: effect of proatherogenic dyslipidemic trio or quartet].
    Zamaklar M; Lalić K; Lalić N
    Med Pregl; 2009; 62 Suppl 3():37-42. PubMed ID: 19702114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis prevention.
    Parhofer KG
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):414-7. PubMed ID: 16151973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of modified oxidation of low density lipoprotein in pathognesis of atherosclerosis].
    Siennicka A; Zapolska-Downar D
    Postepy Hig Med Dosw; 2003; 57(2):219-37. PubMed ID: 12866357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.